Enhabit, Inc. $EHAB Shares Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd lifted its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 188.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 218,284 shares of the company’s stock after acquiring an additional 142,556 shares during the period. Y Intercept Hong Kong Ltd owned 0.43% of Enhabit worth $1,748,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Osaic Holdings Inc. boosted its holdings in shares of Enhabit by 337.5% in the 2nd quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after buying an additional 2,018 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in Enhabit in the third quarter valued at $27,000. Tower Research Capital LLC TRC boosted its stake in Enhabit by 82.9% in the second quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after acquiring an additional 2,059 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Enhabit by 523.1% during the second quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock worth $56,000 after purchasing an additional 4,865 shares during the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after purchasing an additional 8,879 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on EHAB shares. UBS Group raised Enhabit from a “neutral” rating to a “buy” rating and upped their target price for the company from $8.50 to $12.00 in a research report on Thursday, January 8th. TD Cowen upgraded Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Citigroup reiterated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $12.10.

Enhabit Price Performance

Enhabit stock opened at $10.54 on Friday. The company has a market cap of $533.43 million, a P/E ratio of -42.16 and a beta of 1.66. Enhabit, Inc. has a one year low of $6.47 and a one year high of $11.35. The business has a fifty day moving average of $9.74 and a two-hundred day moving average of $8.46. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.05. The firm had revenue of $263.60 million during the quarter, compared to the consensus estimate of $267.08 million. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. As a group, analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.